Alembic Pharmaceuticals completes USFDA bioequivalence inspection
The company said the USFDA bioequivalence inspection at its Vadodara site was completed with no observations.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.